Inolex has announced a major expansion of its US manufacturing capabilities. The expansion, which is set for completion by the second half of 2019, will replace the company’s current US production and warehouse operations with a new flagship plant in Charlotte, North Carolina.
“This is a significant investment to support the growth of our global platform. The flagship plant
allows us to optimise our manufacturing processes and increase our production capacity so that
we can continue to serve our customers and meet the growing global demand for our innovative
technologies,” said David Plimpton, Inolex CEO. “The new Inolex facility also provides the
opportunity for us to better align with our sustainability goals and those of our partners.”
The development marks a key milestone for the company to strategically focus its expertise in
Personal Care. In addition to fulfilling immediate manufacturing and warehouse operations, the
150,000-square foot site offers the opportunity for future expansion of capacity and scope.
“Responsible manufacturing is a cornerstone of Inolex’s Operational Excellence. The
Charlotte plant enables us to enhance production and strengthen business continuity. It’s a hub
to explore new manufacturing processes for our innovation pipeline, and will serve as a gateway
for broader industry collaboration,” said Ted Laarkamp, VP Operations.
More about INOLEX